Persistent inhibition of telomerase induces a severe telomere shortening in human T-cell leukemia virus type-1-infected cells which signals a DNA double-strand break damage response, formation of telomere dysfunction-induced foci and activates the ATM pathway. In turn, activation of ATM and its downstream effectors led to an increased phosphorylation and acetylation on specific residues of p53 known to be involved in transcriptional activation. Disruption of Mdm2-p53 complexes coupled with increased proteasomal degradation of MDMX further enhanced reactivation of p53 transcription, ultimately leading to senescence of tumor cells. Induction of senescence in these T-cells was associated with an increased expression of p21, p16 and activation of GSK3b. Our results support the cancer-aging model and demonstrate that the halt of aging in cancer cells can be reversed through reactivation of p53.
Introduction
The human T-cell leukemia virus type-1 (HTLV-I) is the etiologic agent of an aggressive and fatal disease, adult T-cell leukemia/lymphoma (ATL) (Poiesz et al., 1980) . Antiviral therapy with zidovudine (AZT) and interferon-alpha (IFN-a) in these patients has produced longterm clinical remissions in human trials (Gill et al., 1995; Hermine et al., 1995; Matutes et al., 2001; White et al., 2001) . In HTLV-I-infected cells, Tax stimulates endogenous hTERT promoter (Sinha-Datta et al., 2004) . However despite strong telomerase activity, HTLV-Iinfected cells retain short telomeres and enduring treatment of HTLV-I-infected cells with AZT result in telomere attrition and reactivation of p53 transcriptional activities . Retrospective analyses showed that ATL patients carrying a wild-type p53 entered remission following treatment with AZT and IFN, whereas those carrying a mutated, transcriptionally inactive p53 did not respond to the treatment . This finding correlated with the reported estimated 30% failure rate of AZT/IFN treatment in human trials and the approximate percentage of ATL patients carrying a mutated transcriptionally inactive p53 gene (25%), and highlights the essential role played by p53 to elicit senescence in tumor cells.
Critically short telomeres and telomeres unprotected by the telomere-binding protein complex or shelterin are recognized and processed as DNA double-strand break (DSB) (Celli et al., 2006) and become sites for recruitment of numerous proteins involved in DNA damage responses, referred as telomere dysfunctioninduced foci (TIF) (Celli and de Lange, 2005) , leading to activation of the ataxia telangiectasia mutated (ATM) kinase pathway. Activation of ATM stimulates Chk2, which phosphorylates p53 on serine-20, disrupting its interaction with Mdm2 and stabilizing p53 protein in response to DNA damage (Shieh et al., 1997; Chehab et al., 2000b) . HTLV-I Tax interacts with and inhibits functions of Chk1/Chk2 (Haoudi et al., 2003; Park et al., 2004 Park et al., , 2006 . It is well established that HTLV-I Tax oncoprotein inhibits the function of the tumor suppressor p53 protein, although the mechanism of p53 inactivation in HTLV-I biology is still debated (Grassmann et al., 2005) . MDMX binds to and inhibits p53 transcriptional activity (Shvarts et al., 1996) . Human tumor cell lines retaining wild-type p53 often overexpress MDMX, suggesting that MDMX may play a role in p53 inactivation during tumorigenesis (Ramos et al., 2001) . We previously found a decrease in MDMX levels following persistent inhibition of telomerase in HTLV-I-transformed cells, suggesting that MDMX downregulation may be involved in reactivation of p53-dependent transcription in HTLV-I-transformed cells in response to telomere attrition. This study aimed at understanding the basis for telomere attrition-induced reactivation of p53 function and senescence of HTLV-I leukemic cells. We found that telomere shortening leads to the activation of a DSB response, formation of TIF and ATM activation. In turn, this stimulates the phosphorylation and acetylation of p53, decreasing its interaction with Mdm2 and MDMX and reactivation of p53 transcriptional activities. Our results provide new insights into the molecular mechanisms associated with shortened telomere-induced senescence in HTLV-I leukemic cells.
Results
Telomere attrition in HTLV-I leukemia cell lines activates formation of TIF and a DNA damage ATM response Telomere attrition induces a DSB damage signal that activates the ATM kinase through autophosphorylation at serine-1981 (Bakkenist and Kastan, 2003) . ATM activation leads to Thr-68 phosphorylation and activation of downstream kinase Chk2 (Matsuoka et al., 1998) . We have previously demonstrated that long-term AZT treatment in HTLV-I-transformed cells leads to telomere attrition . This prompted us to investigate if such telomere attrition may initiate a DNA damage response that contributes to the reactivation of p53 functions in HTLV-I cells. In agreement with our previous studies, persistent inhibition of telomerase activity in HTLV-I leukemia cell lines resulted in a significant reduction in telomere length, 67 and 71% in MT-2 and C10MJ cells, respectively (data not shown). Since studies have suggested that shortened telomeres may be recognized as DSB damages, we tested whether telomere shortening in HTLV-I leukemic cells induced a DNA damage signal. Western blot analysis revealed an increased phosphorylation of ATM at serine-1981 (Figure 1a) , indicative of an activation of this kinase in response to telomere shortening in both C10MJ and MT2. Specific phosphorylation of Chk2 and SMC1 confirmed activation of ATM ( Figure 1a , and not shown). However, short-term treatment with AZT (24 h) did not cause any difference in the phosphorylation of ATM, suggesting that activation of ATM is due to telomere loss and not a direct effect of AZT (Figure 1b) . Recent studies have shown that critically short or uncapped telomeres result in formation of TIF and accumulation of DNA damage response factors, such as 53BP1, phospho-g-H2AX, Rad17, phospho-ATM and Mre11 at telomeric ends. Consistent with these findings, HTLV-I cells with short telomeres were positive for TIF formation (Figure 1c) . The mediators that relay the signal from dysfunctional telomeres to the DSB and ATM kinase are unknown. Since short telomeres have been associated with aneuploidy, we next performed karyotypic analysis of parental cells and cells with shortened telomeres in which DSB damage signal was detected. Differences observed in treated cells with short telomeres include small numeric changes, losses or gains of entire chromosomes that may reflect mitotic defects. Six of 20 metaphases had loss of chromosome 17, and eight of 20 metaphases had loss of chromosome 20 not observed in any parental cell metaphases. Six of 20 metaphases had gain of chromosome 8 compared with parental cell metaphases (data not shown). Overall, there was no evidence of severe aneuploidy or genomic instability. Our data suggest that enforced telomere shortening can induce a DSB damage signal and formation of TIFs before telomere size reaches the critical fusogenic and instability stage. On the other hand, the functional status of p53 may be important, since severe aneuploidy was detected in breast cancer cells with shorten telomeres only when p53 was inactive (He et al., 2006) . Telomere attrition reactivates p53 A Datta and C Nicot
Reactivation of p53 transcriptional activity is associated with a specific phosphorylation acetylation pattern and promotes senescence Following DNA damage, p53 undergoes post-translational modifications including phosphorylation of Ser-6, 9, 15 and 20, converting p53 into a transcriptionally active protein (Siliciano et al., 1997) . In HTLV-Itransformed cells, p53 is phosphorylated on Ser-15 and Ser-392 (Pise-Masison et al., 1998) . Our data show that telomere shortening-induced ATM/Chk2 activation significantly increases the phosphorylation of p53 on Ser-9, Ser-15 and Ser-20 ( Figure 2a ). The p300/c-AMP response element-binding (CREB)-binding protein (CBP) and p300-associated factor (PCAF) acetylate the C terminus of p53 at Lys-373/382 (p300/CBP) and Lys-320 (PCAF) (Liu et al., 1999) . Phosphorylation of p53 at Ser-15 increases acetylation of p53 (Lambert et al., 1998) . C10MJ and LAF cells and their counterparts in which telomere size was shortened were tested for acetylation of p53. Consistent with reactivation of p53 transcription, we found an increase in acetylation at both Lys-373/382 and Lys-320 ( Figure 2b ). However, short-term treatment of AZT in these cells did not cause significant change in phosphorylation/acetylation status when compared with control cells, suggesting that these effects are dependent upon telomere shortening-induced DSB damage signals, rather than a direct effect of AZT (data not shown). N terminus phosphorylation of p53 decreases MDM2-p53 interactions, allowing Mdm2 to bind to other partners and preventing degradation of p53. MDMX-MDM2 interactions lead to ubiquitination and degradation of MDMX in response to DNA damage (Pan and Chen, 2003) . The relative amount of p53 bound to MDM2 was analysed by immunoprecipitation and western blot. We found that in AZT-treated sample p53 is mainly free of MDM2 (Figure 2c) . Consistent with the reactivation of p53 in these cells, the relative amount of MDMX bound to p53 was also drastically reduced ( Figure 2c ). In fact in AZT-treated cells MDMX proteasomal degradation was impaired (data not shown). Consistent with our previous results, HTLV-I cells with short telomeres eventually entered into a senescence phase, as demonstrated by increased expression of p21 WAF and p16 ink4 and decreased Ser-9 phosphorylation of glycogen synthase kinase 3b (GSK3b) (Figure 2d ).
Phosphorylation of p53 at serine-20 is important for the reactivation of p53-dependent transcription in HTLV-I-infected cells Activation of Chk2 causes Ser-20 phosphorylation of p53 and stabilization of p53 in response to DNA damage. Since in HTLV-I-infected cells phosphorylation of p53 on Ser-20 is inhibited, we hypothesized that Telomere attrition reactivates p53 A Datta and C Nicot lack of phosphorylation of p53 on Ser-20 may be critical to p53 inactivation in HTLV-I-infected cells. To test that hypothesis, we substituted p53 Ser-20 to alanine (A) and to phospho-mimetic residue, glutamic acid (E). Luciferase assays with a p53-responsive element (pG13Luc) in p53-null Saos-2 cells showed B45-50% reduction in p53 activity when cotransfected with expression plasmids for p53 and HTLV-I Tax (Figure 3a) . These reduction levels in p53 activity by Tax are in accordance with previous reports in other cell lines. Importantly, we found that Tax's ability to suppress p53 transcription was reduced, B20% compared with B45-50% when Ser-20 was changed to phospho-mimetic amino-acid residue (Figure 3a) , demonstrating that phosphorylation status of p53 at Ser-20 is an important factor for Tax-mediated repression of p53 transcription. To further demonstrate a role of Chk2 in p53 repression in HTLV-I-infected cells, we transduced C10MJ cells with a lentivirus vector expressing a previously characterized potent dominantnegative inhibitor of Chk2 (D342A). Cells were g-irradiated to stimulate a p53 response, and target gene expression was monitored by reverse transcription-PCR (RT-PCR). As expected from our previous studies , AZT-treated cells show significant increased expression of p21, bax and mdm2 as a result of p53 reactivation (Figure 3b) . Interestingly, these cells transduced with a dominant-negative Chk2 D342A have lower expression of p21, bax and mdm2 (Figure 3b ). These data suggest the existence of a Chk2-dependent and a Chk2-independent pathway involved in repression of p53 in HTLV-I-infected cells. Possible candidates are Chk1 or ATM, which both phosphorylate p53.
The p53 repressor MDMX is overexpressed in HTLV-1-transformed cells and in ex vivo ATL samples MDM2-related protein MDMX is a negative regulator of p53 function, which is overexpressed in a wide spectrum of human tumors that retain wild-type p53 (Gu et al., 2002) . We investigated the expression levels of MDMX in both HTLV-I cell lines and ATL patients and found that, except for C10MJ, HTLV-I-transformed cells overexpressed MDMX (Figure 4a ). Importantly, increased MDMX expression was readily detected in freshly isolated and uncultured ATL samples when compared with normal peripheral blood mononuclear cell (PBMC) (Figure 4b ). To gain insights into the mechanisms underlying MDMX overexpression in HTLV-I-infected cells, we transfected Saos-2 (p53-null cells) with HTLV-I Tax. To verify whether Tax transcriptionally activated MDMX promoter, we analysed the endogenous levels of MDMX mRNA by quantitative real-time RT-PCR in Saos-2 cells transfected with Tax. We found that Tax expression upregulated the endogenous MDMX transcript more than threefold (Figure 4c ). We also found that expression of Tax alone in these cells caused an increase in MDMX protein levels (Figure 4d, lanes 1 and 2) . There was however no significant change in the protein level of MDMX when p53 was added along with Tax ( Figure 4d, lanes 3 and 4) . Since MDMX is a negative regulator of p53 transcriptional functions (Li et al., 2002; Sabbatini and McCormick, 2002) , we investigated whether MDMX is involved in p53 repression in HTLV-I cells. To test that hypothesis, we transfected double knockout p53 (À/À) MDMX (À/À) mouse embryonic fibroblasts (MEF) cells with a p53-responsive element (pG13Luc) and expression plasmids for p53, Tax and MDMX. As illustrated in Figure 4e , expression of Tax caused about 63% repression of p53 activity in these assays. However, cotransfection along with MDMX further increased Tax-mediated p53 inhibition to 93% or an additional fivefold. These results suggest that p53 repression by Tax in HTLV-I cells is mediated by two mechanisms MDMX-dependent and independent. 
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Discussion
In this study, we have identified the molecular mechanisms underlying p53 reactivation in HTLV-I-transformed cells treated with AZT. Persistent telomerase inhibition led to telomere attrition, formation of TIF and triggers a DNA damage response signal that activates the ATM pathway. In this study, we also found that reactivation of p53 transcription in HTLV-I cells carrying short telomeres was associated with an increased phosphorylation of residues Ser-9 -15 and -20 and increased acetylation by CBP/p300 and PCAF ( Figure 5 ). We found activation of ATM, phosphorylation of downstream targets including Chk2, which stimulates phosphorylation of p53 at Ser-20. Phosphorylation of p53 at Ser-20 disrupted the p53-MDM2 binding, rendering MDM2 free for ubiquitination and proteasomal degradation of MDMX. This leads to p53 reactivation in AZT-treated cells by elimination of two critical negative regulators of p53 namely MDM2 and MDMX. In HTLV-I expressing cells, Tax represses Chk2 kinase activity and inhibits phosphorylation of p53 on Ser-20. Here, we demonstrate that Ser-20 phosphorylation status is an important step in Taxmediated p53 inhibition, as replacement of Ser-20 by constitutive phospho-mimetic Glu-20 in p53, hampered
Tax-mediated repression of p53. These effects depended upon telomere shortening-induced activation of ATM/ Chk2. No effect on ATM activation was detected after short treatment with AZT (48 h), as indicated by the lack of Chk2 activation and lack of p53 phosphorylation on Ser-20 (data not shown). We previously found Telomere attrition reactivates p53 A Datta and C Nicot elevated p21 WAF expression in senescent HTLV-I-infected cells with enforced telomere shortening . Here, we report that p53 reactivation also increased expression of p16ink, consistent with involvement of the Ink4 proteins p16 and p15 in T-lymphocyte senescence. We also found that phosphorylation of GSK3b was significantly decreased, implicating the PKB-GSK3b signaling in T-cell senescent pathway. Recent studies have showed that following DNA damage response, MDMX-MDM2 interactions lead to ubiquitination and degradation of MDMX. A role of MDMX in p53 repression in HTLV-I-infected cells has not been previously investigated. In this study, we demonstrate that MDMX is expressed at high levels in ATL tumor cells in vivo and generally highly expressed in HTLV-I-transformed cells. We found that Tax can stimulate transcription from the MDMX promoter, leading to higher protein expression. Using MEF double knockout for p53 and MDMX, we found that complementation with exogenous MDMX further enhanced Tax's ability to repress p53-dependent transcription. Our data demonstrate that MDMX is a player in the inactivation of p53 in HTLV-I-infected cells. In this study, we found that telomere shortening induces a DSB damage response that leads to the reactivation of p53, in part through Chk2 and MDMX.
Materials and methods

Cell lines and plasmids
Jurkat (ATCC), CEM 174 (ATCC) and HTLV-I cell-lines were maintained in RPMI 1640 supplemented with 50 mM AZT (CalBiochem, La Jolla, CA, USA) every 3 days until growth arrest. Saos-2 cells and the p53À/À MDMXÀ/À DKO MEFs (gift from Dr G Lozano) were grown in Dulbecco's modified Eagle's medium.
Patients' samples were obtained after informed consent and in agreement with regulations for the protection of human subjects according to the NIH guidelines. ATL patients referred to acute stage of the disease as defined by the percentage of circulating tumor cells. The pG13Luc and expression plasmids for p53 and Tax have been reported earlier. The expression plasmid for MDMX was gifted by Dr J Chen. Single amino-acid changes of p53 S20A and S20E was made by PCR using QuikChange site-directed mutagenesis kit (Stratagene, La Jolla, CA, USA), with pcDNA3.1 as parent vector. The appropriate mutation in each construct was verified by sequencing. Chk2 (D342A) dominant negative was provided by Dr Halazonetis (Chehab et al., 2000a) .
Transfection, luciferase and TRAP assays The p53 activity was assessed by transfection using the p53-responsive reporter construct pG13Luc (Effectene, Qiagen, Valencia, CA, USA). The luciferase assay was carried out with Luciferase Reporter assay system (Promega, Madison, WI, USA). The cell lysates of AZT-treated and untreated MT2 and C10MJ cells was measured by telomerase repeat amplification protocol (TRAP) assay using the Trapeze Telomerase detection kit (Chemicon, Temecula, CA, USA).
Western blots and immunofluorescence
Phosphorylation and acetylation antibodies for p53 and GSK3b serine-9 were from Cell Signaling Technology (Danvers, MA, USA); ATM (Ser-1981) and Chk2 (Thr-68) were from Rockland (Gilbertsville, PA, USA). Primary antibodies to ATM, Chk2, p53, MDMX, GSK3b, p16, p21 and actin were from Santa Cruz Biotechnology (Santa Cruz, CA, USA). Secondary antibodies were from Santa Cruz Biotechnology. The anti-TRF1 and anti-phospho-ATM (Ser-139) antibodies were from Imgenex (San Diego, CA, USA) and Cell Signaling Technology, respectively. For detection of TIFs, cells were cytospun and fixed in 4% paraformaldehyde, permeabilized in 10% Triton X-100, blocked with 5% bovine serum albumin, incubated with 1:100 dilution of TRF-1 antibody (Santa Cruz Biotechnology), washed and incubated with Texas-Red at 1:2000 dilution (Invitrogen, Carlsbad, CA, USA). The slides were washed and then incubated with fluorescein isothiocyanate-conjugated p-ATM antibody (2 mg/ml) (Rockland, Giblertsville, PA, USA) washed and mounted. The Z-stack images were acquired by Nikon Eclipse TE 2000-S.
Real-time RT-PCR Total RNA was isolated from untransfected or Tax (1 mg)-transfected Saos2 cells by Trizol, DnaseI treated and reverse transcribed. The resulting cDNA was analysed by real-time PCR using human MDMX (forward primer: 5 0 -CAGTAT CAGAGCAGTTAGGTGTTGG-3 0 ; reverse primer: 5 0 -CTGA ATACCAATCCTTCCTCAAGGCCC-3 0 ) and glyceraldehyde 3-phosphate dehydrogenase (GAPDH) (forward primer: 5 0 -GAAGGTGAAGGTCGGACTC-3 0 ; reverse primer: 5 0 -GA AGATGGTGATGGGATTTC-3 0 ) primer sets. The authenticity of the PCR products was verified by melting curve analysis.
